List of products in the National Drug Code with proprietary name . Pembrolizumab is used to treat cancer. It works by changing the action of your own immune system, directing it to attack cancer cells. Pembrolizumab belongs to a class of drugs known as monoclonal antibodies.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
12714-090 PembrolizumabSolutionBoehringer Ingelheim Pharma Gmbh And Co. KgDrug For Further Processing